LIN28B and hepatocellular carcinoma: In Huh-7 cells and primary (“HCC1/2”) human HCC cells, LIN28B-AS1 siRNA (“S1”) inhibited cell viability (Fig. 2i) and BrdU incorporation (Fig. 2j).